Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients

Atherosclerosis

Volumn 164, Issue 1, 2002, Pages 147-152

  Miettinen, Tatu A ^a   Gylling, Helena ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cholesterol absorption; Cholesterol synthesis; Coronary artery disease; Non cholesterol sterols; Plant sterols; Simvastatin

Indexed keywords

CAMPESTEROL; CHOLESTEROL; LATHOSTEROL; SIMVASTATIN; STEROL; CHOLESTANOL; DESMOSTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SITOSTEROL DERIVATIVE;

ABSORPTION; ARTICLE; BIOSYNTHESIS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PRECURSOR; PRIORITY JOURNAL; REDUCTION; SCANDINAVIA; BLOOD;

CHOLESTANOL; CHOLESTEROL; DESMOSTEROL; HUMAN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; SIMVASTATIN; SITOSTEROLS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0035996367     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00054-0     Document Type: Article

References (19)

1. Inhibition of dietary cholesterol absorption during lovastatin (mevinolin) treatment
2. Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects
3. Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol
4. Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects
5. Baseline noncholesterol sterols and treatment effect in a subgroup of the Scandinavian Simvastatin Survival Study (4S)
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
7. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
8. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population
9. Detection of changes in human cholesterol metabolism
10. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions
11. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans
12. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver
13. Serum plant sterols and their relation to cholesterol absorption
14. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men
15. Non-cholesterol sterols and bile acid production in hypercholesterolemic patients with ileal by-pass
16. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol
17. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia
18. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia
19. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolemia